Читать книгу Transporters and Drug-Metabolizing Enzymes in Drug Toxicity - Albert P. Li - Страница 10

List of Contributors

Michael Arand Institute of Pharmacology and Toxicology University of Zürich Zürich Switzerland

Kristin Ashby Division of Bioinformatics and Biostatistics National Center for Toxicological Research U.S. Food and Drug Administration Jefferson AR USA

Kim L.R. Brouwer Division of Pharmacotherapy and Experimental Therapeutics UNC Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA

Gian Camenisch ADME Department of PK Sciences Translational Medicine Novartis Institutes for Bio Medical Research Basel Switzerland

Minjun Chen Division of Bioinformatics and Biostatistics National Center for Toxicological Research U.S. Food and Drug Administration Jefferson AR USA

Ann K. Daly Translational and Clinical Research Institute Newcastle University Newcastle upon Tyne UK

Mark P. Grillo Myo Kardia, Inc.Brisbane CA USA

Paavo Honkakoski Division of Pharmacotherapy and Experimental Therapeutics UNC Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA

School of Pharmacy Faculty of Health Sciences University of Eastern Finland Kuopio Finland

Tao Hu Department of Pharmaceutical Sciences University of Maryland School of Pharmacy Baltimore MD USA

Felix Huth ADME Department of PK Sciences Translational Medicine Novartis Institutes for Bio Medical Research Basel Switzerland

Vlasia Kastrinou‐Lampou ADME Department of PK Sciences Translational Medicine Novartis Institutes for Bio Medical Research Basel Switzerland

Institute of Pharmacology and Toxicology University of Zürich Zürich Switzerland

Stefanie Kennon‐Mc Gill Department of Environmental and Occupational Health Fay W. Boozman College of Public Health University of Arkansas for Medical Sciences Little Rock AR USA

Gerd A. Kullak‐Ublick Department of Clinical Pharmacology and Toxicology University Hospital Zürich University of Zurich Zürich Switzerland

Mechanistic Safety CMO & Patient Safety Global Drug Development Novartis Basel Switzerland

Albert P. Li In vitro ADMET Laboratories, Inc. Columbia MD USA

Stacey Line Department of Pharmacology and Therapeutics University of Manitoba Winnipeg MBCanada

Chuang Lu Sanofi USWaltham MA USA

Kazuya Maeda Laboratory of Molecular Pharmacokinetics Graduate School of Pharmaceutical Sciences The University of Tokyo Bunkyo‐ku Tokyo Japan

Mitchell R. McGill Department of Environmental and Occupational Health Fay W. Boozman College of Public Health University of Arkansas for Medical Sciences Little Rock AR USA

Donald Miller Department of Pharmacology and Theurapetics Max Rady College of Medicine University of Manitoba Winnipeg MB Canada

William A. Mturphy Division of Pharmacotherapy and Experimental Therapeutics UNC Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill NC USA

Birk Poller ADME Department of PK Sciences Translational Medicine Novartis Institutes for Bio Medical Research Basel Switzerland

Nur A. Safa Department of Pharmacology and Therapeutics University of Manitoba Winnipeg MB Canada

Chitra Saran Division of Pharmacotherapy and Experimental Therapeutics UNC Eshelman School of Pharmacy, and Department of Pharmacology UNC School of Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA

Hongbing Wang Department of Pharmaceutical Sciences University of Maryland School of Pharmacy Baltimore MD USA

Qingping Wang Sanofi US Waltham MA USA

Yue Wu Division of Bioinformatics and Biostatistics National Center for Toxicological Research U.S. Food and Drug Administration Jefferson AR USA

Yan Zhang DMPK Nuvation Bio, Inc. New York NY USA